Funding Details
- Awarder
- Inbox
- Date Award
- June 02, 2022
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$200,000,000
Company Info
- Company Description
- Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.
- Market
- Therapeutics for inflammatory and allergic diseases
- Location
-
Waltham,
MA,
USA
- Coinvestors
- Access Biotechnology, Altshuler Shaham Provident Funds, Decheng Capital, HBM Healthcare Investments, Maruho Co., Omega Funds, OrbiMed Advisors, Samsara BioCapital, TCG
Links